These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 2192787)
1. Drug-induced parkinsonism and other movement disorders. Ross RT Can J Neurol Sci; 1990 May; 17(2):155-62. PubMed ID: 2192787 [TBL] [Abstract][Full Text] [Related]
2. [Study of extrapyramidal manifestations induced by neuroleptics]. Bordeleau JM; Tétreault L Rev Can Biol; 1972; 31():Suppl:247-53. PubMed ID: 4403291 [No Abstract] [Full Text] [Related]
3. [Extrapyramidal symptoms during the use of neuroleptics]. Ditfurth HV Nervenarzt; 1967 Apr; 38(4):151-5. PubMed ID: 4382350 [No Abstract] [Full Text] [Related]
4. Neuromuscular effects of long-term phenothiazine medication, electroconvulsive therapy and leucotomy. Demars JP J Nerv Ment Dis; 1966 Jul; 143(1):73-9. PubMed ID: 5334365 [No Abstract] [Full Text] [Related]
5. The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy. Turunen S; Achté KA Psychiatr Q; 1967; 41(2):268-79. PubMed ID: 4383787 [No Abstract] [Full Text] [Related]
6. Drug-induced extrapyramidal disorders. Chase TN Res Publ Assoc Res Nerv Ment Dis; 1972; 50():448-71. PubMed ID: 4341954 [No Abstract] [Full Text] [Related]
7. [Anatomo-clinical aspects of Parkinson's disease and parkinsonian syndromes]. Gainotti G Riv Neurol; 1978; 48(2):143-92. PubMed ID: 351788 [No Abstract] [Full Text] [Related]
8. Drug-induced parkinsonism: a review. Montastruc JL; Llau ME; Rascol O; Senard JM Fundam Clin Pharmacol; 1994; 8(4):293-306. PubMed ID: 7851836 [TBL] [Abstract][Full Text] [Related]
9. Parkinson's syndrome: aetiological factors and certain clinical features. Sutherland JM Aust N Z J Med; 1971 May; 1():Suppl 1:29-34. PubMed ID: 4949272 [No Abstract] [Full Text] [Related]
11. Extrapyramidal motor disorders due to toxic effect of phenothiazines. Tikare SK; Tikare SS J Indian Med Assoc; 1972 Jan; 58(2):39-42. PubMed ID: 5017799 [No Abstract] [Full Text] [Related]
12. Lithium interferes with reserpine-induced dopamine depletion. Reches A; Hassan MN; Jackson V; Fahn S Ann Neurol; 1983 Jun; 13(6):671-3. PubMed ID: 6410976 [TBL] [Abstract][Full Text] [Related]
13. [Cerebral degenerative change in association with dyskinesia following neuroleptic treatment (author's transl)]. Ule G; Struwe O Nervenarzt; 1978 May; 49(5):268-70. PubMed ID: 673082 [No Abstract] [Full Text] [Related]
14. The pharmacology of parkinsonism (a review). Klawans HL Dis Nerv Syst; 1968 Dec; 29(12):805-16. PubMed ID: 4388368 [No Abstract] [Full Text] [Related]
15. Drug-induced movement disorders. North RR Postgrad Med; 1971 Sep; 50(3):180-5. PubMed ID: 5092993 [No Abstract] [Full Text] [Related]
16. Effect of different neuroleptics in tardive dyskinesia and parkinsonism. A video-controlled multicenter study with chlorprothixene, perphenazine, haloperidol and haloperidol + biperiden. Nordic Dyskinesia Study Group. Psychopharmacology (Berl); 1986; 90(4):423-9. PubMed ID: 2880362 [TBL] [Abstract][Full Text] [Related]